glp-1 receptor expression papillary thyroid carcinoma Is it safe to start a GLP‑1 agonist (e.g., exenatide, liraglutide) in a patient with nodules? GLP-1 and Family History of

that if they just have more discipline and resolve, they can successfully lose weight

These medications are typically injected, which presents additional challenges when it comes to packing, transporting, and administering them while traveling

However, it also noted that weight loss tended to plateau around the 60-week mark

Nat Reviews Disease Primers

GLP-1 agents, while costly and not yet guideline-endorsed for prevention, offer broader metabolic benefits without inherent bleeding risk

This is due, at least in part, to recent outcome trial data supporting the use of select GLP-1 RAs and SGLT-2 inhibitors to mitigate cardiovascular and renal risks in at-risk patients